Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Adacel Revaccination 4-5 Years Post-First Dose
NCT00347958Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Sanofi. Started Aug 2006; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00347958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347958.